• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2H-色烯和 7H-呋喃色烯衍生物选择性抑制肿瘤相关的人碳酸酐酶 IX 和 XII 同工型。

2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms.

机构信息

Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria, Monserrato, Italy.

CIQUP-IMS/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.

出版信息

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2270183. doi: 10.1080/14756366.2023.2270183. Epub 2023 Oct 23.

DOI:10.1080/14756366.2023.2270183
PMID:37870190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11003494/
Abstract

Tumour associated carbonic anhydrases (CAs) IX and XII have been recognised as potential targets for the treatment of hypoxic tumours. Therefore, considering the high pharmacological potential of the chromene scaffold as selective ligand of the IX and XII isoforms, two libraries of compounds, namely 2H-chromene and 7H-furo-chromene derivatives, with diverse substitution patterns were designed and synthesised. The structure of the newly synthesised compounds was characterised and their inhibitory potency and selectivity towards human CA off target isoforms I, II and cancer-associated CA isoforms IX and XII were evaluated. Most of the compounds inhibit CA isoforms IX and XII with no activity against the I and II isozymes. Thus, while the potency was influenced by the substitution pattern along the chromene scaffold, the selectivity was conserved along the series, confirming the high potential of both 2H-chromene and 7H-furo-chromene scaffolds for the design of isozyme selective inhibitors.

摘要

肿瘤相关碳酸酐ases(CAs)IX 和 XII 已被认为是治疗缺氧肿瘤的潜在靶点。因此,考虑到色烯骨架作为 IX 和 XII 同工型的选择性配体具有很高的药理学潜力,设计并合成了两个化合物库,即 2H-色烯和 7H-呋喃色烯衍生物,具有不同的取代模式。新合成化合物的结构进行了表征,并评估了它们对人 CA 非靶标同工型 I、II 和癌症相关 CA 同工型 IX 和 XII 的抑制效力和选择性。大多数化合物抑制 CA 同工型 IX 和 XII,对 I 和 II 同工型没有活性。因此,虽然构效关系受到色烯骨架取代模式的影响,但整个系列中保持了选择性,证实了 2H-色烯和 7H-呋喃色烯骨架在设计同工型选择性抑制剂方面具有很高的潜力。

相似文献

1
2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms.2H-色烯和 7H-呋喃色烯衍生物选择性抑制肿瘤相关的人碳酸酐酶 IX 和 XII 同工型。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2270183. doi: 10.1080/14756366.2023.2270183. Epub 2023 Oct 23.
2
Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.碳酸酐酶抑制剂。新型 N-取代的 N'-(2-芳甲基硫代-4-氯-5-甲基苯磺酰)胍的合成及分子结构及其对人胞质同工酶 I 和 II 以及跨膜肿瘤相关同工酶 IX 和 XII 的抑制作用。
Eur J Med Chem. 2014 Jan;71:135-47. doi: 10.1016/j.ejmech.2013.10.081. Epub 2013 Nov 10.
3
Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.碳酸酐酶抑制剂。含色酮和芳族磺酰胺部分的席夫碱及其锌配合物对胞质/肿瘤相关碳酸酐酶同工酶I、II、IX和XII的抑制作用。
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3096-101. doi: 10.1016/j.bmcl.2005.04.055.
4
Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.设计、合成及生物评价香豆素-3-甲酰胺类化合物作为碳酸酐酶 IX 和 XII 的选择性抑制剂。
Bioorg Chem. 2019 May;86:386-392. doi: 10.1016/j.bioorg.2019.02.004. Epub 2019 Feb 5.
5
N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.N-β-糖苷磺酰胺类是癌症相关碳酸酐酶同工酶 IX 和 XII 的选择性抑制剂。
Bioorg Med Chem Lett. 2011 Aug 1;21(15):4447-50. doi: 10.1016/j.bmcl.2011.06.031. Epub 2011 Jun 16.
6
Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.新型席夫碱对碳酸酐酶同工型I、II、IX和XII的抑制作用:肿瘤相关同工型相对于胞质同工型的选择性抑制剂的鉴定。
Bioorg Med Chem. 2014 Nov 1;22(21):5883-90. doi: 10.1016/j.bmc.2014.09.021. Epub 2014 Sep 21.
7
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.S-取代的 2-巯基喹唑啉-4(3H)-酮和 4-乙基苯磺酰胺类化合物可作为强效和选择性的人碳酸酐酶 IX 和 XII 抑制剂。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):733-743. doi: 10.1080/14756366.2020.1742117.
8
Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.苯乙炔基苯磺酰胺区域异构体强烈且选择性地抑制跨膜的、肿瘤相关的碳酸酐酶同工酶 IX 和 XII,而对胞质同工酶 I 和 II 没有作用。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5892-6. doi: 10.1016/j.bmcl.2011.07.090. Epub 2011 Jul 30.
9
Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII.乙酰唑胺的有机钌(II)配合物能强烈抑制人碳酸酐酶同工酶 I、II、IX 和 XII。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):388-393. doi: 10.1080/14756366.2018.1547288.
10
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.香豆素和补骨脂素衍生物对碳酸酐酶 IX 和 XII 的选择性抑制。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):685-692. doi: 10.1080/14756366.2021.1887171.

引用本文的文献

1
Synthesis of Chromene-linked Bis-indole Derivatives as Selective Tumor-associated Carbonic Anhydrase IX Inhibitors.苯并二氢吡喃连接的双吲哚衍生物作为选择性肿瘤相关碳酸酐酶IX抑制剂的合成
Anticancer Agents Med Chem. 2025;25(6):399-410. doi: 10.2174/0118715206341087241029064945.

本文引用的文献

1
Anticancer Activity of Sunitinib Analogues in Human Pancreatic Cancer Cell Cultures under Normoxia and Hypoxia.在常氧和低氧条件下,舒尼替尼类似物对人胰腺癌细胞培养物的抗癌活性。
Int J Mol Sci. 2023 Mar 12;24(6):5422. doi: 10.3390/ijms24065422.
2
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment.新型吡唑并[3,4-d]嘧啶类双重Src/Bcr-Abl 激酶抑制剂的合成及对慢性髓性白血病的治疗作用研究。
Bioorg Chem. 2022 Nov;128:106071. doi: 10.1016/j.bioorg.2022.106071. Epub 2022 Aug 1.
3
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
曲妥珠单抗-德曲妥珠单抗用于既往治疗的 HER2 低表达晚期乳腺癌。
N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5.
4
Effective drug combinations in breast, colon and pancreatic cancer cells.在乳腺癌、结肠癌和胰腺癌细胞中有效的药物组合。
Nature. 2022 Mar;603(7899):166-173. doi: 10.1038/s41586-022-04437-2. Epub 2022 Feb 23.
5
Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases: A Systematic Review and Meta-analysis.晚期非小细胞肺癌合并间质性肺疾病患者免疫检查点抑制剂治疗的临床结局:一项系统评价和荟萃分析
Chest. 2022 Jun;161(6):1675-1686. doi: 10.1016/j.chest.2021.12.656. Epub 2022 Jan 11.
6
Efficacy of targeted therapy in patients with HER2-positive non-small cell lung cancer: A systematic review and meta-analysis.曲妥珠单抗联合紫杉类药物治疗 HER2 阳性转移性乳腺癌的有效性和安全性的 Meta 分析。
Br J Clin Pharmacol. 2022 May;88(5):2019-2034. doi: 10.1111/bcp.15155. Epub 2021 Dec 21.
7
An overview on the recently discovered iota-carbonic anhydrases.关于最近发现的ι-碳酸酐酶的概述。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1988-1995. doi: 10.1080/14756366.2021.1972995.
8
Carbonic anhydrase IX: a regulator of pH and participant in carcinogenesis.碳酸酐酶IX:pH调节剂与致癌作用参与者
J Clin Pathol. 2021 Feb 22. doi: 10.1136/jclinpath-2020-207073.
9
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.香豆素和补骨脂素衍生物对碳酸酐酶 IX 和 XII 的选择性抑制。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):685-692. doi: 10.1080/14756366.2021.1887171.
10
Recent advancements of coumarin-based anticancer agents: An up-to-date review.香豆素类抗癌剂的最新进展:最新综述。
Bioorg Chem. 2020 Oct;103:104163. doi: 10.1016/j.bioorg.2020.104163. Epub 2020 Aug 26.